Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/16/22
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 11/30/24
Due: 11/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy | NCT05393284 | Valo Health, Inc. | user2@example.com | None | 2022-08-16 | 2024-08-31 | 2025-08-31 | - | - | 2025-07-14 |
| Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) | NCT05327855 | Valo Health, Inc. | user2@example.com | None | 2022-09-30 | 2024-11-30 | 2025-11-30 | - | - | 2025-07-14 |